🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

REGENXBIO Inc.

RGNX Healthcare
$6.35 $-0.4 (-5.93%)
Market Cap: $328.28 M
Gurus Holding
5
Popularity Rank
#1688
% of Shares Held
3.13%
Net Activity (Q1 2026)
-$5.74 M

Guru Ownership Trend

Guru Analysis for REGENXBIO Inc. (RGNX)

REGENXBIO Inc. (RGNX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $10.26 M.

Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $5.74 M net outflow during the quarter.

Recent activity highlights Steven Cohen who increased their stake by 318.7%. Conversely, Cliff Asness reduced exposure by 22.8%.

Key Holders

Recent Activity Breakdown (Q1 2026)

+$1.69 M
Total Buy Value
New Buys 1
Additions 1
-$7.43 M
Total Sell Value
Reductions 2
Sold Out 2

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
4
Net Buyers
2

FAQs for REGENXBIO Inc. (RGNX)

Major holders include Cliff Asness ($8.81 M), Renaissance Technologies (RenTech) ($2.56 M), Steven Cohen ($1.17 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.62 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $5.74 M, with 2 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited RGNX. The total reported sell value was $7.43 M.

Yes, 1 managers opened new positions in RGNX, and 1 increased their existing holdings. The total reported buy value was $1.69 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Reduce -22.8% 1,051,712 $8.81 M Q1 2026
0.00% Reduce -8.4% 305,286 $2.56 M Q1 2026
0.00% Add 318.7% 139,791 $1.17 M Q1 2026
0.01% New Buy 95,400 $799,452 Q1 2026
0.00% 24,310 $203,718 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form